scholarly journals Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema

2017 ◽  
Vol Volume 11 ◽  
pp. 2107-2112 ◽  
Author(s):  
Ilkka Laine ◽  
Juha-Matti Lindholm ◽  
Petteri Ylinen ◽  
Raimo Tuuminen
2009 ◽  
Vol 44 (2) ◽  
pp. 154-159 ◽  
Author(s):  
Amir Ali Ahmadi ◽  
Jean Y. Chuo ◽  
Alexander Banashkevich ◽  
Patrick E. Ma ◽  
David A.L. Maberley

2014 ◽  
Vol 24 (5) ◽  
pp. 761-770 ◽  
Author(s):  
Elvira Farese ◽  
Gilda Cennamo ◽  
Nunzio Velotti ◽  
Claudio Traversi ◽  
Michele Rinaldi ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-3 ◽  
Author(s):  
Manish Nagpal ◽  
Vikram Mehta ◽  
Kamal Nagpal

Macular edema secondary to retinal vein occlusion is commonly being treated with off-label intravitreal bevacizumab with good outcomes. A significant reduction in macular edema and improvement in visual acuity is seen following such a treatment with no serious adverse effects. In the reported case, a full-thickness macular hole was noticed one month after intravitreal bevacizumab for macular edema secondary to hemicentral retinal vein occlusion. On a detailed review of the pre- and postoptical coherence tomography scans, it was realized that there was a preexisting stage 2-3 macular hole which was masked by the hemorrhages and edema at the fovea and the macular hole had progressed following the injection.


Sign in / Sign up

Export Citation Format

Share Document